These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24200193)

  • 21. Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists.
    Wang S; Ren J; Li R; Li X; Zhangsun D; Wu Y; Luo S
    Bioorg Chem; 2021 Jul; 112():104875. PubMed ID: 33823404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
    Wang S; Zhao C; Liu Z; Wang X; Liu N; Du W; Dai Q
    Mar Drugs; 2015 May; 13(6):3259-75. PubMed ID: 26023835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a potent and selective α3β4 nicotinic acetylcholine receptor antagonist from an α-conotoxin synthetic combinatorial library.
    Chang YP; Banerjee J; Dowell C; Wu J; Gyanda R; Houghten RA; Toll L; McIntosh JM; Armishaw CJ
    J Med Chem; 2014 Apr; 57(8):3511-21. PubMed ID: 24649848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
    Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
    Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of an α 4/7-Conotoxin LvIF from
    Guo M; Yu J; Zhu X; Zhangsun D; Luo S
    Mar Drugs; 2021 Jul; 19(7):. PubMed ID: 34356823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists.
    Hone AJ; Rueda-Ruzafa L; Gordon TJ; Gajewiak J; Christensen S; Dyhring T; Albillos A; McIntosh JM
    J Neurochem; 2020 Jul; 154(2):158-176. PubMed ID: 31967330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Determinants of Species Specificity of α-Conotoxin TxIB towards Rat and Human α6/α3β4 Nicotinic Acetylcholine Receptors.
    Xie T; Qin Y; Zhao J; Dong J; Qi P; Zhang P; Zhangsun D; Zhu X; Yu J; Luo S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
    Hone AJ; Scadden M; Gajewiak J; Christensen S; Lindstrom J; McIntosh JM
    Mol Pharmacol; 2012 Nov; 82(5):972-82. PubMed ID: 22914547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
    McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
    Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
    Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 3/4- and 3/6-Subfamily Variants of α-Conotoxins GI and MI Exhibit Potent Inhibitory Activity against Muscular Nicotinic Acetylcholine Receptors.
    Ma X; Huang Q; Yu S; Xu S; Huang Y; Zhao Z; Xiao X; Dai Q
    Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
    Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
    J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning, Synthesis and Functional Characterization of a Novel α-Conotoxin Lt1.3.
    Chen J; Liang L; Ning H; Cai F; Liu Z; Zhang L; Zhou L; Dai Q
    Mar Drugs; 2018 Mar; 16(4):. PubMed ID: 29614714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
    McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
    J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors.
    Nicke A; Samochocki M; Loughnan ML; Bansal PS; Maelicke A; Lewis RJ
    FEBS Lett; 2003 Nov; 554(1-2):219-23. PubMed ID: 14596943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Selectivity of an α-Conotoxin LvIA Analogue for α3β2 Nicotinic Acetylcholine Receptors Is Mediated by β2 Functionally Important Residues.
    Zhu X; Pan S; Xu M; Zhang L; Yu J; Yu J; Wu Y; Fan Y; Li H; Kasheverov IE; Kudryavtsev DS; Tsetlin VI; Xue Y; Zhangsun D; Wang X; Luo S
    J Med Chem; 2020 Nov; 63(22):13656-13668. PubMed ID: 33196189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation kinetics of α-conotoxin TxID.
    Xu P; Xiong Y; Liu Y; Yu S; Zhangsun D; Wu Y; Luo S
    FEBS Open Bio; 2019 Sep; 9(9):1561-1572. PubMed ID: 31278882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
    Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
    Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
    Kryukova EV; Ivanov IA; Lebedev DS; Spirova EN; Egorova NS; Zouridakis M; Kasheverov IE; Tzartos SJ; Tsetlin VI
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel conotoxin inhibitor of Kv1.6 channel and nAChR subtypes defines a new superfamily of conotoxins.
    Imperial JS; Bansal PS; Alewood PF; Daly NL; Craik DJ; Sporning A; Terlau H; López-Vera E; Bandyopadhyay PK; Olivera BM
    Biochemistry; 2006 Jul; 45(27):8331-40. PubMed ID: 16819832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.